Describir: A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of <i> Helicobacter pylori </i> infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and <i> Enterococcus faecium ENCfa-68 </i>